AVXL – Anavex Life Sciences Corp.
Anavex Life Sciences Corp.AVXL
$9.48Name : Anavex Life Sciences Corp.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $809,325,632.00
EPSttm : -0.56
Anavex Life Sciences Corp.
$9.48
0.94%$0.09Float Short %
30.55
Margin Of Safety %
Put/Call OI Ratio
0.36
EPS Next Q Diff
-0.01
EPS Last/This Y
-0.04
EPS This/Next Y
2.91
Price
9.48
Target Price
34.33
Analyst Recom
1
Performance Q
-0.63
Relative Volume
2.99
Beta
0.71
Ticker: AVXL
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-06-02 | AVXL | 7.55 | 0.35 | 0.57 | 65648 |
| 2025-06-03 | AVXL | 7.83 | 0.35 | 0.24 | 65695 |
| 2025-06-04 | AVXL | 7.72 | 0.35 | 0.01 | 65795 |
| 2025-06-05 | AVXL | 7.77 | 0.35 | 0.22 | 65980 |
| 2025-06-06 | AVXL | 8.27 | 0.35 | 0.56 | 66294 |
| 2025-06-09 | AVXL | 7.92 | 0.34 | 0.04 | 66716 |
| 2025-06-10 | AVXL | 8.11 | 0.34 | 0.02 | 67171 |
| 2025-06-11 | AVXL | 8.19 | 0.34 | 0.09 | 67478 |
| 2025-06-12 | AVXL | 8.19 | 0.34 | 2.77 | 67654 |
| 2025-06-13 | AVXL | 8.03 | 0.34 | 0.63 | 67668 |
| 2025-06-16 | AVXL | 8.6 | 0.34 | 0.01 | 67704 |
| 2025-06-17 | AVXL | 8.91 | 0.34 | 0.07 | 68076 |
| 2025-06-18 | AVXL | 9.03 | 0.34 | 0.09 | 68117 |
| 2025-06-20 | AVXL | 9.07 | 0.34 | 0.38 | 67767 |
| 2025-06-23 | AVXL | 9.3 | 0.35 | 0.78 | 64054 |
| 2025-06-24 | AVXL | 9.56 | 0.35 | 0.53 | 64869 |
| 2025-06-25 | AVXL | 9.41 | 0.36 | 0.57 | 65689 |
| 2025-06-26 | AVXL | 9.57 | 0.36 | 0.80 | 66132 |
| 2025-06-27 | AVXL | 9.47 | 0.36 | 0.14 | 66440 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-06-02 | AVXL | 7.55 | -3.6 | - | -0.56 |
| 2025-06-03 | AVXL | 7.84 | -3.6 | - | -0.56 |
| 2025-06-04 | AVXL | 7.72 | -3.6 | - | -0.56 |
| 2025-06-05 | AVXL | 7.78 | -3.6 | - | -0.56 |
| 2025-06-06 | AVXL | 8.28 | -3.6 | - | -0.56 |
| 2025-06-09 | AVXL | 7.93 | -3.6 | - | -0.56 |
| 2025-06-10 | AVXL | 8.11 | -3.6 | - | -0.56 |
| 2025-06-11 | AVXL | 8.19 | -3.6 | - | -0.56 |
| 2025-06-12 | AVXL | 8.22 | -3.6 | - | -0.56 |
| 2025-06-13 | AVXL | 8.03 | -3.6 | - | -0.56 |
| 2025-06-16 | AVXL | 8.60 | -3.6 | - | -0.56 |
| 2025-06-17 | AVXL | 8.92 | -3.6 | - | -0.56 |
| 2025-06-18 | AVXL | 9.03 | -3.6 | - | -0.56 |
| 2025-06-20 | AVXL | 9.09 | -3.6 | - | -0.56 |
| 2025-06-23 | AVXL | 9.30 | -3.6 | - | -0.56 |
| 2025-06-24 | AVXL | 9.54 | -3.6 | - | -0.56 |
| 2025-06-25 | AVXL | 9.40 | -3.6 | - | -0.56 |
| 2025-06-26 | AVXL | 9.58 | -3.6 | - | -0.56 |
| 2025-06-27 | AVXL | 9.48 | -3.6 | - | -0.56 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-06-02 | AVXL | 0.00 | 5.99 | 29.19 |
| 2025-06-03 | AVXL | 0.00 | 5.99 | 29.19 |
| 2025-06-04 | AVXL | 0.00 | 5.99 | 29.19 |
| 2025-06-05 | AVXL | 0.00 | 5.99 | 29.19 |
| 2025-06-06 | AVXL | 0.00 | 5.99 | 29.19 |
| 2025-06-09 | AVXL | 0.00 | 6.00 | 29.19 |
| 2025-06-10 | AVXL | 0.00 | 6.00 | 29.19 |
| 2025-06-11 | AVXL | 0.00 | 6.00 | 30.32 |
| 2025-06-12 | AVXL | 0.00 | 6.00 | 30.32 |
| 2025-06-13 | AVXL | 0.00 | 6.00 | 30.32 |
| 2025-06-16 | AVXL | 0.00 | 5.93 | 30.33 |
| 2025-06-18 | AVXL | 0.00 | 5.93 | 30.33 |
| 2025-06-20 | AVXL | 0.00 | 5.93 | 30.33 |
| 2025-06-23 | AVXL | 0.00 | 5.93 | 30.33 |
| 2025-06-24 | AVXL | 0.00 | 5.93 | 30.33 |
| 2025-06-25 | AVXL | 0.00 | 5.93 | 30.33 |
| 2025-06-26 | AVXL | 0.00 | 5.93 | 30.55 |
| 2025-06-27 | AVXL | 0.00 | 5.93 | 30.55 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.13
Avg. EPS Est. Current Quarter
-0.14
Avg. EPS Est. Next Quarter
-0.14
Insider Transactions
Institutional Transactions
5.93
Beta
0.71
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
10
Growth Score
21
Sentiment Score
72
Actual DrawDown %
69.9
Max Drawdown 5-Year %
-88.3
Target Price
34.33
P/E
Forward P/E
6.73
PEG
P/S
P/B
8.11
P/Free Cash Flow
EPS
-0.56
Average EPS Est. Cur. Y
-0.56
EPS Next Y. (Est.)
2.35
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
2.99
Return on Equity vs Sector %
-71.2
Return on Equity vs Industry %
-53.3
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.09
EBIT Estimation
Anavex Life Sciences Corp.Sector: Healthcare
Industry: Biotechnology
Employees: 42
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States. The company's lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome. It also provides ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer's disease. Its preclinical drug candidates include ANAVEX 1-41 for the treatment of depression, stroke, and neurogenerative disease; ANAVEX 1066 for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. Anavex Life Sciences Corp. was incorporated in 2004 and is headquartered in New York, New York.
stock quote shares AVXL – Anavex Life Sciences Corp. Stock Price stock today
news today AVXL – Anavex Life Sciences Corp. stock forecast ,stock prediction 2023 2024 2025
marketwatch AVXL – Anavex Life Sciences Corp. yahoo finance google finance
stock history AVXL – Anavex Life Sciences Corp. invest stock market
stock prices AVXL premarket after hours
ticker AVXL fair value insiders trading